Zobrazeno 1 - 10
of 1 382
pro vyhledávání: '"Bouda, J"'
Autor:
Presl J; Department of Gynecology and Obstetrics, Faculty of Medicine in Pilsen, University Hospital Pilsen, Charles University, 323 00 Pilsen, Czech Republic., Havelka P; Department of Gynecology and Obstetrics, KNTB a.s Zlin, 762 75 Zlin, Czech Republic., Weinberger V; Department of Obstetrics and Gynecology, University Hospital Brno and Medical Faculty, Masaryk University, 625 00 Brno, Czech Republic., Ovesna P; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic., Fekete P; Department of Gynecological Oncology, St. Elizabeth Cancer Institute, 811 08 Bratislava, Slovakia., Fruhauf F; Department of Obstetrics, Gynecology and Neonatology First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic., Jedryka M; Gynecological Oncology Department, Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw Medical University, 53-413 Wroclaw, Poland., Bystricky B; Department of Oncology, Faculty Hospital Trencin, Faculty of Healthcare, Alexander Dubcek University of Trencin, 911 06 Trencin, Slovakia., Strojna A; Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland.; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, 45136 Essen, Germany., Volodko N; Department of Oncology and Radiology, Danylo Halytsky Lviv National Medical University, 79010 Lviv, Ukraine., Matylevich O; Gynecologic Oncology Division, NN Alexandrov National Cancer Centre, 223040 Minsk, Belarus., Herboltova P; Department of Gynecology and Obstetrics, Faculty of Medicine in Pilsen, Charles University, 306 05 Pilsen, Czech Republic.; Department of Gynecology and Obstetrics, Jihlava Hospital, 586 01 Jihlava, Czech Republic., Blecharz P; Department of Gynecologic Oncology, National Cancer Institute, M. Sklodowska-Curie Memorial Institute, 31-115 Cracow, Poland., Kalist V; Department of Gynecology and Obstetrics, KNTB a.s Zlin, 762 75 Zlin, Czech Republic., Ehrlichova L; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, 625 00 Brno, Czech Republic., Stranik P; Department of Gynecology and Obstetrics, Faculty of Medicine in Pilsen, University Hospital Pilsen, Charles University, 323 00 Pilsen, Czech Republic., Masak L; Department of Gynecological Oncology, St. Elizabeth Cancer Institute, 811 08 Bratislava, Slovakia., Poncova R; Department of Obstetrics, Gynecology and Neonatology First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic., Czekanski A; Gynecological Oncology Department, Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw Medical University, 53-413 Wroclaw, Poland., Chaloupkova B; Department of Gynecology and Obstetrics, KNTB a.s Zlin, 762 75 Zlin, Czech Republic., Koblizkova M; Department of Obstetrics and Gynecology, University Hospital Brno and Medical Faculty, Masaryk University, 625 00 Brno, Czech Republic., Smoligova V; Department of Gynecology and Obstetrics, Faculty of Medicine in Pilsen, University Hospital Pilsen, Charles University, 323 00 Pilsen, Czech Republic., Hrabalova M; Department of Gynecology and Obstetrics, KNTB a.s Zlin, 762 75 Zlin, Czech Republic., Jaksicova A; Department of Oncology, KNTB a.s Zlin, 762 75 Zlin, Czech Republic., Linkesch P; Department of Gynecology and Obstetrics, KNTB a.s Zlin, 762 75 Zlin, Czech Republic., Viktora L; Department of Obstetrics and Gynecology, University Hospital Brno and Medical Faculty, Masaryk University, 625 00 Brno, Czech Republic., Bouda J; Department of Gynecology and Obstetrics, Faculty of Medicine in Pilsen, University Hospital Pilsen, Charles University, 323 00 Pilsen, Czech Republic., Vlasak P; Department of Gynecology and Obstetrics, Faculty of Medicine in Pilsen, University Hospital Pilsen, Charles University, 323 00 Pilsen, Czech Republic., Kostun J; Department of Gynecology and Obstetrics, Faculty of Medicine in Pilsen, University Hospital Pilsen, Charles University, 323 00 Pilsen, Czech Republic.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Oct 23; Vol. 16 (21). Date of Electronic Publication: 2024 Oct 23.
Autor:
Michal M; Bioptical Laboratory, Ltd, Pilsen, Czech Republic; Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic. Electronic address: michael.michal@biopticka.cz., Agaimy A; Institute of Pathology, Friedrich Alexander University Erlangen-Nürnberg, University Hospital, Erlangen, Germany., Croce S; Department of BioPathology, Anticancer Center, Institut Bergonié, Bordeaux, France., Mechtersheimer G; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Gross JM; Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland., Xing D; Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland., Bell DA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Gupta S; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Mosaieby E; Bioptical Laboratory, Ltd, Pilsen, Czech Republic; Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic., Martínek P; Bioptical Laboratory, Ltd, Pilsen, Czech Republic., Klubíčková N; Bioptical Laboratory, Ltd, Pilsen, Czech Republic; Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic., Michalová K; Bioptical Laboratory, Ltd, Pilsen, Czech Republic; Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic., Bouda J; Department of Gynecology and Obstetrics, Charles University, Faculty of Medicine in Pilsen and Charles University Hospital Pilsen, Pilsen, Czech Republic., Fínek J; Department of Oncology and Radiotherapeutics, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic., Hernandez T; Department of Pathology and Laboratory Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York., Michal M; Bioptical Laboratory, Ltd, Pilsen, Czech Republic; Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic., Schoolmeester JK; Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida., Ondič O; Bioptical Laboratory, Ltd, Pilsen, Czech Republic; Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Sep; Vol. 37 (9), pp. 100552. Date of Electronic Publication: 2024 Jun 26.
Publikováno v:
QIC Vol.12 No.5&6 pp0394-0402 (2012)
The lack of perfect randomness can cause significant problems in securing communication between two parties. McInnes and Pinkas proved that unconditionally secure encryption is impossible when the key is sampled from a weak random source. The adversa
Externí odkaz:
http://arxiv.org/abs/1109.1943
We present a fair and optimistic quantum contract signing protocol between two clients that requires no communication with the third trusted party during the exchange phase. We discuss its fairness and show that it is possible to design such a protoc
Externí odkaz:
http://arxiv.org/abs/1106.2922
Autor:
Holý P; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Hlaváč V; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Šeborová K; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Šůsová S; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Tesařová T; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Rob L; Department of Gynecology and Obstetrics, Third Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic., Hruda M; Department of Gynecology and Obstetrics, Third Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic., Bouda J; Department of Gynecology and Obstetrics, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Bartáková A; Department of Gynecology and Obstetrics, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Mrhalová M; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University, Prague, Czech Republic., Kopečková K; Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic., Al Obeed Allah M; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Špaček J; University Hospital Hradec Králové, Hradec Kralove, Czech Republic., Sedláková I; University Hospital Hradec Králové, Hradec Kralove, Czech Republic., Souček P; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Václavíková R; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
Publikováno v:
International journal of cancer [Int J Cancer] 2024 Jul 01; Vol. 155 (1), pp. 104-116. Date of Electronic Publication: 2024 Mar 06.
Autor:
Tomasova K; Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 00, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655/77, 32300, Pilsen, Czech Republic., Seborova K; Toxicogenomics Unit, National Institute of Public Health, Srobarova 48, 100 42, Prague, Czech Republic.; Laboratory of Pharmacogenomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655/76, 323 00, Pilsen, Czech Republic., Kroupa M; Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 00, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655/77, 32300, Pilsen, Czech Republic., Horak J; Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 00, Prague, Czech Republic.; Third Faculty of Medicine, Charles University, Ruska 87, 100 00, Prague, Czech Republic., Kavec M; Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 00, Prague, Czech Republic.; Department of Oncology, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic., Vodickova L; Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 00, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655/77, 32300, Pilsen, Czech Republic.; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 128 00, Prague, Czech Republic., Rob L; Department of Gynecology and Obstetrics, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic., Hruda M; Department of Gynecology and Obstetrics, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic., Mrhalova M; Department of Pathology and Molecular Medicine, Second Faculty of Medicine and Motol University Hospital, Charles University, Prague, Czech Republic., Bartakova A; Department of Gynecology and Obstetrics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Bouda J; Department of Gynecology and Obstetrics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Fleischer T; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Kristensen VN; Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Vodicka P; Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 142 00, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655/77, 32300, Pilsen, Czech Republic.; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 128 00, Prague, Czech Republic., Vaclavikova R; Toxicogenomics Unit, National Institute of Public Health, Srobarova 48, 100 42, Prague, Czech Republic.; Laboratory of Pharmacogenomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655/76, 323 00, Pilsen, Czech Republic.
Publikováno v:
Heliyon [Heliyon] 2024 Jun 29; Vol. 10 (13), pp. e33525. Date of Electronic Publication: 2024 Jun 29 (Print Publication: 2024).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alléaume, R., Branciard, C., Bouda, J., Debuisschert, T., Dianati, M., Gisin, N., Godfrey, M., Grangier, P., Länger, T., Lütkenhaus, N., Monyk, C., Painchault, P., Peev, M., Poppe, A., Pornin, T., Rarity, J., Renner, R., Ribordy, G., Riguidel, M., Salvail, L., Shields, A., Weinfurter, H., Zeilinger, A.
Publikováno v:
In Theoretical Computer Science 4 December 2014 560 Part 1:62-81
Autor:
Kolk, W.L. van der, Zee, A.G.J. van der, Slomovitz, B.M., Baldwin, P.J.W., Doorn, H.C. van, Hullu, J.A. de, Velden, J. van der, Gaarenstroom, K.N., Slangen, B.F.M., Kjolhede, P., Brannstrom, M., Vergote, I., Holland, C.M., Coleman, R., Dorst, E.B.L. van, Driel, W.J. van, Nunns, D., Widschwendter, M., Nugent, D., DiSilvestro, P.A., Mannel, R.S., Tjiong, M.Y., Boll, D., Cibula, D., Covens, A., Provencher, D., Runnebaum, I.B., Monk, B.J., Zanagnolo, V., Tamussino, K., Oonk, M.H.M., Levenback, C.F., Hermans, R.H., Bouda, J., Sharma, A., Luesley, D., Ellis, P., Cruickshank, D.J., Duncan, T.J., Kieser, K., Palle, C., Spirtos, N.M., O'Malley, D.M., Leitao, M.M., Geller, M., Dhar, K., Asher, V., Tobias, D.H., Borgfeldt, C., Lea, J.S., Lood, M., Bailey, J., Eyjolfsdottir, B., Attard-Montalto, S., Tewari, K.S., Persson, P., Manchanda, R., Jensen, P., L. van le, GROINSS-V I II Participants
Publikováno v:
Gynecologic Oncology, 167(1), 3-10. Elsevier Science
Gynecologic Oncology, 167(1), 3-10. Academic Press Inc.
Gynecologic Oncology, 167(1). ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic oncology, 167(1), 3-10. Academic Press Inc.
On behalf of all GROINSS-V I and II participants 2022, ' Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe ', Gynecologic Oncology, vol. 167, no. 1, pp. 3-10 . https://doi.org/10.1016/j.ygyno.2022.07.017
Gynecologic Oncology, 167, 3-10
Gynecologic Oncology, 167(1), 3-10. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 167(1), 3-10. Academic Press
Gynecologic Oncology, 167, 1, pp. 3-10
Van der Kolk, W L, Van der Zee, A G J, Slomovitz, B M, Baldwin, P J W, Van Doorn, H C, De Hullu, J A, Van der Velden, J, Gaarenstroom, K N, Slangen, B F M, Kjolhede, P, Brännström, M, Vergote, I, Holland, C M, Coleman, R, Van Dorst, E B L, Van Driel, W J, Nunns, D, Widschwendter, M, Nugent, D, DiSilvestro, P A, Mannel, R S, Tjiong, M Y, Boll, D, Cibula, D, Covens, A, Provencher, D, Runnebaum, I B, Monk, B J, Zanagnolo, V, Tamussino, K, Oonk, M H M & On behalf of all GROINSS-V I and II participants 2022, ' Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe ', Gynecologic Oncology, vol. 167, no. 1, pp. 3-10 . https://doi.org/10.1016/j.ygyno.2022.07.017
Gynecologic Oncology, 167(1), 3-10. Academic Press Inc.
Gynecologic Oncology, 167(1). ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic oncology, 167(1), 3-10. Academic Press Inc.
On behalf of all GROINSS-V I and II participants 2022, ' Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe ', Gynecologic Oncology, vol. 167, no. 1, pp. 3-10 . https://doi.org/10.1016/j.ygyno.2022.07.017
Gynecologic Oncology, 167, 3-10
Gynecologic Oncology, 167(1), 3-10. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 167(1), 3-10. Academic Press
Gynecologic Oncology, 167, 1, pp. 3-10
Van der Kolk, W L, Van der Zee, A G J, Slomovitz, B M, Baldwin, P J W, Van Doorn, H C, De Hullu, J A, Van der Velden, J, Gaarenstroom, K N, Slangen, B F M, Kjolhede, P, Brännström, M, Vergote, I, Holland, C M, Coleman, R, Van Dorst, E B L, Van Driel, W J, Nunns, D, Widschwendter, M, Nugent, D, DiSilvestro, P A, Mannel, R S, Tjiong, M Y, Boll, D, Cibula, D, Covens, A, Provencher, D, Runnebaum, I B, Monk, B J, Zanagnolo, V, Tamussino, K, Oonk, M H M & On behalf of all GROINSS-V I and II participants 2022, ' Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe ', Gynecologic Oncology, vol. 167, no. 1, pp. 3-10 . https://doi.org/10.1016/j.ygyno.2022.07.017
Objective. Optimal management of the contralateral groin in patients with early-stage vulvar squamous cell carcinoma (VSCC) and a metastatic unilateral inguinal sentinel lymph node (SN) is unclear. We analyzed patients who participated in GROINSS-V I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4540cea710bbfd8f16388b07208bbb36
https://cris.maastrichtuniversity.nl/en/publications/75fc8298-6acf-4589-92f1-71a88d2b6312
https://cris.maastrichtuniversity.nl/en/publications/75fc8298-6acf-4589-92f1-71a88d2b6312
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.